| NCT Number | NCT07244588 |
| Lead Sponsor | Mark Ezzat Gerges |
| Conditions | Early Stage Breast Cancer |
| Enrollment | 30 participants |
| Start Date | 2025-12 |
| Primary Completion | 2026-01 (estimated) |
| Study Completion | 2026-12 (estimated) |
| Updated on ClinicalTrials.gov | 2025-11-24 |